Please login to the form below

Not currently logged in
Email:
Password:

Insmed appoints FDA's Dr Eugene Sullivan

He joinsthe US biopharmaceutical firm as its chief medical officer

US biopharmaceutical company Insmed has appointed former deputy director of the FDA Dr Eugene Sullivan to be its new chief medical and scientific officer.

Dr Sullivan was most recently vice president of global regulatory affairs at AstraZeneca and prior to that, during a career that has so far spanned more than 20 years focusing on pulmonary and orphan diseases, served at United Therapeutics.

He also spent a seven-year spell from 1999 at the FDA, where he held several positions, including deputy director of its Pulmonary and Allergy Products division.

In his new role Dr Sullivan will report to Will Lewis, president and chief executive officer, who said: “Gene is actively involved as an author, lecturer and advisor on medical and regulatory matters affecting orphan drugs and pulmonary diseases.

“His experience will provide new insight and valuable perspective as we advance Arikayce, INS1009 and our other pipeline candidates while building Insmed into a leading biopharmaceutical company.”

30th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics